Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High sustained virological response rate to combination therapy in genotype 1 patients with histologically mild hepatitis C.

Journal of gastrointestinal and liver diseases : JGLD - 1 Mar 2009

Gheorghe Liana, Iacob Speranta, Grigorescu Mircea, Sporea Ioan, Sirli Roxana, Damian Dana, Gheorghe Cristian, Iacob Razvan

Abstract excerpt

BACKGROUND: Patients with mild hepatitis C have a significant risk of disease progression at medium- and long-term follow-up and should be considered for antiviral therapy. AIM: To evaluate the rate of sustained viral response (SVR) and predictive factors of SVR in HCV genotype 1 patients with mi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Interferon-alpha
Share to Interferon alpha-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Cirrhosis

Share to Polyethylene Glycols

Share to Ribavirin

Share to Romania

Share to Transaminases

Source

Identifiers

PMID: 19337634

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19337634-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High sustained virological response rate to combination therapy in genotype 1 patients with histologically mild hepatitis C.PMID 19337634Read ↗

[Chronic hepatitis C: patients with mild disease].Semantic proximity Read ↗

Why do I treat my patients with mild hepatitis C?Semantic proximity Read ↗

Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon.Semantic proximity Read ↗

Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation.Semantic proximity Read ↗

Why I do not treat patients for mild disease.Semantic proximity Read ↗

Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patients.Semantic proximity Read ↗

Sustained virological response according to the type of early virological response in HCV and HCV/HIV.Semantic proximity Read ↗

Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing.Semantic proximity Read ↗

Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

Re-treatment with highly purified nIFNα in Mexican nonresponder patients with chronic genotype 1 hepatitis C.Semantic proximity Read ↗

Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1.Semantic proximity Read ↗

Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.